Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq: GILD) as part of Gilead’s Relink grant program. CDA Foundation will disperse the grant to qualifying tax-exempt organizations to contact diagnosed but untreated patients with hepatitis C virus (HCV) or hepatitis B virus (HBV) infection to bring them back into care.

Despite the availability of existing treatment and vaccination options; in the United States an estimated 2.4 million people are living with HCV, and 850,000 are estimated to be living with HBV, according to the U.S. Department of Health and Human Services. Both viruses are responsible for increasing rates of cirrhosis, liver cancer, liver failure and premature deaths. According to CDA Foundation’s research, the risk of developing cancer for someone infected with HCV or HBV infection is the same as someone who smokes one pack of cigarettes per day. HCV and HBV are associated not only with liver cancer but also increased risk of lymphoma, diabetes, insulin resistance, renal disease, fatigue, cognitive impairment, depression, impaired quality of life, arthritis, fibromyalgia and cardiovascular disorders.

Recognizing the growing continued risk of viral hepatitis, the World Health Organization set a global target to eliminate viral hepatitis as a major public health threat by 2030. Despite the availability of oral drugs with high cure rates for HCV and effective therapies for HBV, this goal has been impeded because many patients diagnosed with viral hepatitis are unaware of their infection, do not seek follow-up care, or delay treatment. According to a recent study by U.S. CDC, less than 30% of all Medicaid, Medicare, and private insurance recipients initiate treatment within one year of being diagnosed in the U.S. The Relink grant program aims to identify and work to bridge the gaps that remain in linking patients back to necessary care and treatment.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19 and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

“Hepatitis B and C viruses are highly cancer causing. The Gilead Relink grant is an important example of how public and private partnership can shape viral hepatitis elimination programs that will help the United States achieve WHO targets by 2030,” said Homie Razavi, Founder and Managing Director, CDA Foundation. “In order to improve viral hepatitis patient outcomes in the United States, we must ensure that individuals not only have access to but are also guided toward affordable and effective prevention, care and treatment services.”

“Gilead has been committed to improving the lives of people living with liver disease for more than two decades, and we are thrilled to expand our support to healthcare organizations through the new Gilead Relink grant program,” said Macky Natha, Vice President, Medical Affairs, Gilead Sciences. “As we work toward eliminating viral hepatitis as a public health threat by 2030, we must address barriers to treatment by relinking the people who have been lost in the process, and that’s what the CDA Foundation and other impactful organizations will help accomplish through this program.”

For more information, please visit https://cdafound.org/relink or contact CDA Foundation at relink@cdafound.org.

About Center for Disease Analysis Foundations

CDA Foundation is a non-profit organization that seeks to help eliminate HBV and HCV globally by 2030 by providing countries across the world with verified epidemiological data, disease burden and economic impact modeling, smart intervention strategies, access to affordable diagnostics and treatments, innovative financing, and knowledge-sharing partnerships to eliminate these deadly infections. It works with more than 110 countries globally and 26 US states on their viral hepatitis elimination programs. It is headquartered in Lafayette, Colorado.

Contact: Homie Razavi
  hrazavi@cdafound.org


Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

TIN LIÊN QUAN

Cowlitz Tribal Foundation Celebrates 2022 Grant Recipients

The Cowlitz Tribal Foundation’s philanthropic efforts topped $8 million in 2022, with grants distributed to 110 nonprofits in Clark County and throughout...

Terracon Foundation Awards Over $90,000 in Grants

Grants and scholarships made to universities and organizations throughout U.S....

Seattle Humane to Address Lack of Affordable Veterinary

Bellevue, Washington, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Nearly 50 million pets in the U.S. cannot access even the most basic veterinary care. Due to cost...

DentaQuest Opens Nominations for 2023 Health Equity Heroes

The awards recognize individuals and organizations working toward equitable access to oral care and optimal health outcomes...

THỦ THUẬT HAY

Hướng dẫn cách nâng cấp lên Windows 10 từ USB

Qua phần 1, mình đã hướng dẫn các bạn cách Cách nâng cấp lên Windows 10 trực tiếp trên trang chủ của microsoft. Tiếp theo, là cách nâng cấp lên Windows 10 từ USB.

Sửa lỗi treo logo trên phiên bản mới nhất “PUBG Tàu” – Rules Of Survival

Để có thể kiểm tra máy tính mình đang sử dụng có card màn hình hay là không, bạn hãy vào thanh tìm kiếm START > RUN (đối với windows 7) hay SEARCH ( đối với windows 8, 10) hay có thể sử dụng tổ hợp phím WINDOWS + S

Cách thêm chú thích cho ảnh trên iOS 14 dễ dàng, bạn đã thử chưa?

Nếu iPhone của bạn chưa có tính năng chú thích ảnh thì hãy cập nhật lên hệ điều hành iOS 14 ngay nhé. Bởi sau đây chúng tôi sẽ là hướng dẫn cách thêm chú thích cho ảnh trên iOS 14 mời các bạn cùng thao tác. Hướng dẫn

[Chia sẻ] Để có ảnh đẹp trong những ngày Tết

Tết là một trong những dịp mà mọi người chụp ảnh rất nhiều, và để có những bức ảnh đẹp ngày Tết, mình xin post lại chia sẻ của anh Nguyễn Phúc Lộc về một số thủ thuật và lưu ý khi chụp ảnh, cả bằng điện thoại lẫn máy

Mẹo lạ giúp iPhone chạy nhanh bất ngờ

Có lẽ không bất ngờ khi càng sử dụng lâu, chiếc Iphone của bạn càng trở lên chậm chạp, hay tham khảo những gợi ý dưới đây để giúp chiếc điện thoại của bạn hồi phục 'phong độ' nhé!

ĐÁNH GIÁ NHANH

So sánh iPhone X với LG V30: Liệu LG có thể làm nên bất ngờ?

Khi đặt 2 smartphone này cạnh nhau, bạn sẽ cảm nhận được sự cao cấp trong ngoại hình của bộ đôi sản phẩm này, thậm chí thấy được nhiều nét tương đồng

So sánh iPhone 13 mini và iPhone 13: Nên mua phiên bản nào?

Tương tự iPhone 12, iPhone 13 cũng có 4 tùy chọn bao gồm: iPhone 13 mini, iPhone 13, iPhone 13 Pro và iPhone 13 Pro Max. Mỗi phiên bản đều có ưu điểm riêng, trong số đó bản iPhone 13 mini và iPhone 13 có giá bán dễ

Trên tay Google Pixel 5: thiết kế mảnh mai, màn hình nốt ruồi, giá bán 699USD

Cuộc đua trên thị trường smartphone tầm trung nóng hơn bao giờ hết với sự xuất hiện của sản phẩm mới nhà Google Pixel 5. Hãy cùng chúng tôi trên tay Google Pixel 5 xem nó có gì đặc biệt so với các sản phẩm cùng phân